Insulet
PODD
#1880
Rank
S$14.71 B
Marketcap
S$212.40
Share price
2.94%
Change (1 day)
-44.72%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Market capitalization of Insulet (PODD)

Market cap: S$14.71 Billion

As of July 2026 Insulet has a market cap of S$14.71 Billion. This makes Insulet the world's 1880th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insulet from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026S$14.71 B-43.6%
2025S$26.08 B3.19%
2024S$25.27 B26.33%
2023S$20.01 B-26.99%
2022S$27.40 B10.48%
2021S$24.80 B11.27%
2020S$22.29 B54.1%
2019S$14.46 B125.58%
2018S$6.41 B19.44%
2017S$5.37 B71.47%
2016S$3.13 B2.81%
2015S$3.04 B-11.1%
2014S$3.42 B32.85%
2013S$2.57 B105.53%
2012S$1.25 B8.58%
2011S$1.15 B27.39%
2010S$0.90 B19.87%
2009S$0.75 B167.46%
2008S$0.28 B-67.32%
2007S$0.86 B

End of Day market cap according to different sources

On Jul 2nd, 2026 the market cap of Insulet was reported to be:

S$14.71 Billion
by Nasdaq info icon info icon
S$14.71 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$817.66 B 5,457.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$214.58 B 1,358.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$137.51 B 834.70%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
S$1.397 T 9,401.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
S$1.35 B-90.78%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
S$5.00 B-66.00%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
S$35.50 B 141.33%๐Ÿ‡บ๐Ÿ‡ธ USA